Glioblastoma is a aggressive brain malignancy known for its rapid growth and unresponsiveness more info to typical treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a unique biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is abundantly prod